Authors:
VRIEILING C
COLLETTE L
FOURQUET A
HOOGENRAAD WJ
HORIOT JC
JAGER JJ
PETERSE JL
PIERART M
POORTMANS PM
STRUIKMANS H
VANDERSCHUEREN E
BARTELINK H
Citation: C. Vrieiling et al., THE INFLUENCE OF THE BOOST ON THE COSMETIC OUTCOME AFTER BREAST-CONSERVING THERAPY, European journal of cancer, 34, 1998, pp. 254-254
Authors:
VRIELING C
COLLETTE L
FOURQUET A
HOOGENRAAD WJ
HORIOT JC
JAGER JJ
PETERSE JL
PIERART M
POORTMANS PM
STRUIKMANS H
VANDERSCHUEREN E
BARTELINK H
Citation: C. Vrieling et al., THE HIGHER LOCAL RECURRENCE RATE AFTER BREAST-CONSERVING THERAPY IN YOUNG-PATIENTS EXPLAINED BY LARGER TUMOR SIZE, INCOMPLETE EXCISION AT FIRST ATTEMPT AND SMALLER EXCISION VOLUME, European journal of cancer, 34, 1998, pp. 444-444
Authors:
KAYE SB
MEAD GM
FOSSA S
CULLEN M
DEWIT R
BODROGI I
VANGROENINGEN C
SYLVESTER R
COLLETTE L
STENNING S
DEPRIJCK L
LALLEMAND E
DEMULDER P
Citation: Sb. Kaye et al., INTENSIVE INDUCTION-SEQUENTIAL CHEMOTHERAPY WITH BOP VIP-B COMPARED WITH TREATMENT WITH BEP/EP FOR POOR-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - A RANDOMIZED MEDICAL-RESEARCH-COUNCIL EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER STUDY/, Journal of clinical oncology, 16(2), 1998, pp. 692-701
Authors:
FOSSA SD
KAYE SB
MEAD GM
CULLEN M
DEWIT R
BODROGI I
VANGROENINGEN CJ
DEMULDER PHM
STENNING S
LALLEMAND E
DEPRIJCK L
COLLETTE L
Citation: Sd. Fossa et al., FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY, Journal of clinical oncology, 16(2), 1998, pp. 716-724
Authors:
DENNING DW
MARINUS A
COHEN J
SPENCE D
HERBRECHT R
PAGANO L
KIBBLER C
KCRMERY V
OFFNER F
CORDONNIER C
JEHN U
ELLIS M
COLLETTE L
SYLVESTER R
Citation: Dw. Denning et al., AN EORTC MULTICENTER PROSPECTIVE SURVEY OF INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL PATIENTS - DIAGNOSIS AND THERAPEUTIC OUTCOME, The Journal of infection, 37(2), 1998, pp. 173-180
Authors:
WITJES JA
VANDERMEIJDEN APM
COLLETTE L
SYLVESTER R
DEBRUYNE FMJ
VANAUBEL A
WITJES WPJ
Citation: Ja. Witjes et al., LONG-TERM FOLLOW-UP OF AN EORTC RANDOMIZED PROSPECTIVE TRIAL COMPARING INTRAVESICAL BACILLE CALMETTE-GUERIN-RIVM AND MITOMYCIN-C IN SUPERFICIAL BLADDER-CANCER, Urology, 52(3), 1998, pp. 403-410
Authors:
COLLETTE L
SYLVESTER RJ
DENIS LJ
BOUFFIOUX C
KURTH K
VANDERMEIJDEN AP
PARMAR MKB
PAWINSKI A
Citation: L. Collette et al., THE 3-MONTH RECURRENCE AS A PROGNOSTIC FACTOR FOR THE LONG-TERM OUTCOME IN TATL BLADDER-CANCER - RESULTS OF A COMBINED ANALYSIS OF EORTC AND MRC RANDOMIZED TRIALS OF PROPHYLACTIC TREATMENT, The Journal of urology, 159(5), 1998, pp. 540-540
Authors:
BRAUSI M
KURTH K
VANDERMEIJDEN AP
SYLVESTER RJ
COLLETTE L
Citation: M. Brausi et al., VARIABILITY IN THE 3-MONTH RECURRENCE RATE AFTER TUR IN SUPERFICIAL TRANSITIONAL-CELL CARCINOMA (TCC) OF THE BLADDER - A COMBINED ANALYSIS OF 8 EORTC STUDIES, The Journal of urology, 159(5), 1998, pp. 541-541
Authors:
DEWIT R
STOTER G
SLEIJFER D
NEIJT JP
HUININK WWT
DEPRIJCK L
COLLETTE L
SYLVESTER R
Citation: R. Dewit et al., 4 CYCLES OF BEP VS 4 CYCLES OF VIP IN PATIENTS WITH INTERMEDIATE-PROGNOSIS METASTATIC TESTICULAR NON SEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP, British Journal of Cancer, 78(6), 1998, pp. 828-832
Authors:
DEWIT R
COLLETTE L
SYLVESTER R
DEMULDER PHM
SLEIJFER DT
HUININK WWT
KAYE SB
VANOOSTEROM AT
BOVEN E
STOTER G
Citation: R. Dewit et al., SERUM ALPHA-FETOPROTEIN SURGE AFTER THE INITIATION OF CHEMOTHERAPY FOR NONSEMINOMATOUS TESTICULAR CANCER HAS AN ADVERSE PROGNOSTIC-SIGNIFICANCE, British Journal of Cancer, 78(10), 1998, pp. 1350-1355
Authors:
BLEIBERG H
CONROY T
PAILLOT B
LACAVE AJ
BLIJHAM G
JACOB JH
BEDENNE L
NAMER M
DEBESI P
GAY F
COLLETTE L
SAHMOUD T
Citation: H. Bleiberg et al., RANDOMIZED PHASE-II STUDY OF CISPLATIN AND 5-FLUOROURACIL (5-FU) VERSUS CISPLATIN ALONE IN ADVANCED SQUAMOUS-CELL ESOPHAGEAL CANCER, European journal of cancer, 33(8), 1997, pp. 1216-1220
Authors:
HORIOT JC
BONTEMPS P
BEGG AC
LEFUR R
VANDENBOGAERT W
BOLLA M
NGUYEN T
VANDENWEIJNGAERT D
BERNIER J
LUSINCHI A
STUSCHKE M
LOPEZTORRECILLA D
JANCAR B
COLLETTE L
VANGLABBEKE M
PIERART M
Citation: Jc. Horiot et al., NEW RADIOTHERAPY FRACTIONATION SCHEMES IN HEAD AND NECK CANCERS - THEEORTC TRIALS - A BENCHMARK, European journal of cancer, 33, 1997, pp. 591-591
Citation: L. Collette et Br. Litman, THE PECULIAR ECONOMICS OF NEW BROADCAST NETWORK ENTRY - THE CASE OF UNITED-PARAMOUNT AND WARNER-BROS, Journal of media economics, 10(4), 1997, pp. 3-22
Citation: Bs. Greenberg et L. Collette, THE CHANGING FACES ON TV - A DEMOGRAPHIC-ANALYSIS OF NETWORK TELEVISIONS NEW SEASONS, 1966-1992, Journal of broadcasting & electronic media, 41(1), 1997, pp. 1-13
Authors:
DEWIT R
STOTER G
KAYE SB
SLEIJFER DT
JONES WG
HUININK WWT
REA LA
COLLETTE L
SYLVESTER R
Citation: R. Dewit et al., IMPORTANCE OF BLEOMYCIN IN COMBINATION CHEMOTHERAPY FOR GOOD-PROGNOSIS TESTICULAR NONSEMINOMA - A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER GENITOURINARY TRACT CANCER COOPERATIVE GROUP, Journal of clinical oncology, 15(5), 1997, pp. 1837-1843
Authors:
HORIOT JC
BONTEMPS P
VANDENBOGAERT W
LEFUR R
VANDENWEIJNGAERT D
BOLLA M
BERNIER J
LUSINCHI A
STUSCHKE M
LOPEZTORRECILLA J
BEGG AC
PIERART M
COLLETTE L
Citation: Jc. Horiot et al., ACCELERATED FRACTIONATION (AF) COMPARED TO CONVENTIONAL FRACTIONATION(CF) IMPROVES LOCO-REGIONAL CONTROL IN THE RADIOTHERAPY OF ADVANCED HEAD AND NECK CANCERS - RESULTS OF THE EORTC-22851 RANDOMIZED TRIAL, Radiotherapy and oncology, 44(2), 1997, pp. 111-121
Citation: L. Collette, BETWEEN SACRED AND SECULAR - RESEARCH AND THEORY ON QUASI RELIGION, VOL 4 - GREIL,AL, ROBBINS,T, Review of religious research, 38(3), 1997, pp. 272-273
Authors:
BOLLA M
GONZALEZ D
WARDE P
DUBOIS JB
MIRIMANOFF RO
STORME G
BERNIER J
KUTEN A
STERNBERG C
GIL T
COLLETTE L
PIERART M
Citation: M. Bolla et al., IMPROVED SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED PROSTATE-CANCER TREATED WITH RADIOTHERAPY AND GOSERELIN, The New England journal of medicine, 337(5), 1997, pp. 295-300
Citation: M. Bolla et L. Collette, TREATMENT OF PROSTATE-CANCER WITH GOSERELIN AND RADIOTHERAPY - REPLY, The New England journal of medicine, 337(23), 1997, pp. 1694-1694
Authors:
LEFEBVRE JL
CHEVALIER D
LUBOINSKI B
KIRKPATRICK A
COLLETTE L
SAHMOUD T
Citation: Jl. Lefebvre et al., LARYNX PRESERVATION IN PYRIFORM SINUS CANCER - PRELIMINARY-RESULTS OFA EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PHASE-III TRIAL, Journal of the National Cancer Institute, 88(13), 1996, pp. 890-899
Authors:
VISCOLI C
GIRMENIA C
MARINUS A
COLLETTE L
MARTINO P
LEBAU B
SPENCE D
KRCMERY V
MEUNIER F
Citation: C. Viscoli et al., CANDIDEMIA IN CANCER-PATIENTS - FACTORS ASSOCIATED WITH ETIOLOGY (ALBICANS VS NON-ALBICANS) AND SURVIVAL, Clinical infectious diseases, 23(4), 1996, pp. 31-31
Authors:
HOFF CC
COATES TJ
BARRETT DC
COLLETTE L
EKSTRAND M
Citation: Cc. Hoff et al., DIFFERENCES BETWEEN GAY MEN IN PRIMARY RELATIONSHIPS AND SINGLE MEN -IMPLICATIONS FOR PREVENTION, AIDS education and prevention, 8(6), 1996, pp. 546-559
Authors:
BLIJHAM G
WAGENER T
WILS J
DEGREVE J
BUSET M
BLEIBERG H
LACAVE A
DALMARK M
SELLESLAG J
COLLETTE L
SAHMOUD T
Citation: G. Blijham et al., MODULATION OF HIGH-DOSE INFUSIONAL FLUOROURACIL BY LOW-DOSE METHOTREXATE IN PATIENTS WITH ADVANCED OR METASTATIC COLORECTAL-CANCER - FINAL RESULTS OF A RANDOMIZED EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT OF-CANCER STUDY, Journal of clinical oncology, 14(8), 1996, pp. 2266-2273